Global and United States Monoclonal Antibody Therapeutics Market Size, Status and Forecast 2021-2027

Global and United States Monoclonal Antibody Therapeutics Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monoclonal Antibody Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Humanized Antibody
1.2.3 Human Mouse Chimeric Antibody
1.3 Market by Application
1.3.1 Global Monoclonal Antibody Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cancer
1.3.3 Autoimmune Diseases
1.3.4 Infection
1.3.5 Hematological Diseases
1.3.6 Ophthalmological Diseases
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Monoclonal Antibody Therapeutics Market Perspective (2016-2027)
2.2 Monoclonal Antibody Therapeutics Growth Trends by Regions
2.2.1 Monoclonal Antibody Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Monoclonal Antibody Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Monoclonal Antibody Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Monoclonal Antibody Therapeutics Industry Dynamic
2.3.1 Monoclonal Antibody Therapeutics Market Trends
2.3.2 Monoclonal Antibody Therapeutics Market Drivers
2.3.3 Monoclonal Antibody Therapeutics Market Challenges
2.3.4 Monoclonal Antibody Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Monoclonal Antibody Therapeutics Players by Revenue
3.1.1 Global Top Monoclonal Antibody Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Monoclonal Antibody Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Monoclonal Antibody Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Monoclonal Antibody Therapeutics Revenue
3.4 Global Monoclonal Antibody Therapeutics Market Concentration Ratio
3.4.1 Global Monoclonal Antibody Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monoclonal Antibody Therapeutics Revenue in 2020
3.5 Monoclonal Antibody Therapeutics Key Players Head office and Area Served
3.6 Key Players Monoclonal Antibody Therapeutics Product Solution and Service
3.7 Date of Enter into Monoclonal Antibody Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Monoclonal Antibody Therapeutics Breakdown Data by Type
4.1 Global Monoclonal Antibody Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Monoclonal Antibody Therapeutics Forecasted Market Size by Type (2022-2027)
5 Monoclonal Antibody Therapeutics Breakdown Data by Application
5.1 Global Monoclonal Antibody Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Monoclonal Antibody Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Monoclonal Antibody Therapeutics Market Size (2016-2027)
6.2 North America Monoclonal Antibody Therapeutics Market Size by Type
6.2.1 North America Monoclonal Antibody Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Monoclonal Antibody Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Monoclonal Antibody Therapeutics Market Size by Type (2016-2027)
6.3 North America Monoclonal Antibody Therapeutics Market Size by Application
6.3.1 North America Monoclonal Antibody Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Monoclonal Antibody Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Monoclonal Antibody Therapeutics Market Size by Application (2016-2027)
6.4 North America Monoclonal Antibody Therapeutics Market Size by Country
6.4.1 North America Monoclonal Antibody Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Monoclonal Antibody Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Monoclonal Antibody Therapeutics Market Size (2016-2027)
7.2 Europe Monoclonal Antibody Therapeutics Market Size by Type
7.2.1 Europe Monoclonal Antibody Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Monoclonal Antibody Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Monoclonal Antibody Therapeutics Market Size by Type (2016-2027)
7.3 Europe Monoclonal Antibody Therapeutics Market Size by Application
7.3.1 Europe Monoclonal Antibody Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Monoclonal Antibody Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Monoclonal Antibody Therapeutics Market Size by Application (2016-2027)
7.4 Europe Monoclonal Antibody Therapeutics Market Size by Country
7.4.1 Europe Monoclonal Antibody Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Monoclonal Antibody Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Monoclonal Antibody Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Type
8.2.1 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Application
8.3.1 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Region
8.4.1 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Monoclonal Antibody Therapeutics Market Size (2016-2027)
9.2 Latin America Monoclonal Antibody Therapeutics Market Size by Type
9.2.1 Latin America Monoclonal Antibody Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Monoclonal Antibody Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Monoclonal Antibody Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Monoclonal Antibody Therapeutics Market Size by Application
9.3.1 Latin America Monoclonal Antibody Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Monoclonal Antibody Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Monoclonal Antibody Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Monoclonal Antibody Therapeutics Market Size by Country
9.4.1 Latin America Monoclonal Antibody Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Monoclonal Antibody Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Monoclonal Antibody Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Type
10.2.1 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Application
10.3.1 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Country
10.4.1 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Monoclonal Antibody Therapeutics Introduction
11.1.4 Bayer Revenue in Monoclonal Antibody Therapeutics Business (2016-2021)
11.1.5 Bayer Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Details
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Monoclonal Antibody Therapeutics Business (2016-2021)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Monoclonal Antibody Therapeutics Introduction
11.3.4 Pfizer Revenue in Monoclonal Antibody Therapeutics Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Monoclonal Antibody Therapeutics Introduction
11.4.4 Sanofi Revenue in Monoclonal Antibody Therapeutics Business (2016-2021)
11.4.5 Sanofi Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Monoclonal Antibody Therapeutics Introduction
11.5.4 GlaxoSmithKline Revenue in Monoclonal Antibody Therapeutics Business (2016-2021)
11.5.5 GlaxoSmithKline Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Monoclonal Antibody Therapeutics Introduction
11.6.4 Merck Revenue in Monoclonal Antibody Therapeutics Business (2016-2021)
11.6.5 Merck Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Monoclonal Antibody Therapeutics Introduction
11.7.4 Novartis Revenue in Monoclonal Antibody Therapeutics Business (2016-2021)
11.7.5 Novartis Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Monoclonal Antibody Therapeutics Introduction
11.8.4 AbbVie Revenue in Monoclonal Antibody Therapeutics Business (2016-2021)
11.8.5 AbbVie Recent Development
11.9 Amgen
11.9.1 Amgen Company Details
11.9.2 Amgen Business Overview
11.9.3 Amgen Monoclonal Antibody Therapeutics Introduction
11.9.4 Amgen Revenue in Monoclonal Antibody Therapeutics Business (2016-2021)
11.9.5 Amgen Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Monoclonal Antibody Therapeutics Introduction
11.10.4 Johnson & Johnson Revenue in Monoclonal Antibody Therapeutics Business (2016-2021)
11.10.5 Johnson & Johnson Recent Development
11.11 Bristol-Myers Squibb Company
11.11.1 Bristol-Myers Squibb Company Company Details
11.11.2 Bristol-Myers Squibb Company Business Overview
11.11.3 Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Introduction
11.11.4 Bristol-Myers Squibb Company Revenue in Monoclonal Antibody Therapeutics Business (2016-2021)
11.11.5 Bristol-Myers Squibb Company Recent Development
11.12 Biogen
11.12.1 Biogen Company Details
11.12.2 Biogen Business Overview
11.12.3 Biogen Monoclonal Antibody Therapeutics Introduction
11.12.4 Biogen Revenue in Monoclonal Antibody Therapeutics Business (2016-2021)
11.12.5 Biogen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Monoclonal Antibody Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Humanized Antibody
Table 3. Key Players of Human Mouse Chimeric Antibody
Table 4. Global Monoclonal Antibody Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Monoclonal Antibody Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Monoclonal Antibody Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Monoclonal Antibody Therapeutics Market Share by Regions (2016-2021)
Table 8. Global Monoclonal Antibody Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Monoclonal Antibody Therapeutics Market Share by Regions (2022-2027)
Table 10. Monoclonal Antibody Therapeutics Market Trends
Table 11. Monoclonal Antibody Therapeutics Market Drivers
Table 12. Monoclonal Antibody Therapeutics Market Challenges
Table 13. Monoclonal Antibody Therapeutics Market Restraints
Table 14. Global Monoclonal Antibody Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Monoclonal Antibody Therapeutics Market Share by Players (2016-2021)
Table 16. Global Top Monoclonal Antibody Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Antibody Therapeutics as of 2020)
Table 17. Ranking of Global Top Monoclonal Antibody Therapeutics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Monoclonal Antibody Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Monoclonal Antibody Therapeutics Product Solution and Service
Table 21. Date of Enter into Monoclonal Antibody Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Monoclonal Antibody Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Monoclonal Antibody Therapeutics Revenue Market Share by Type (2016-2021)
Table 25. Global Monoclonal Antibody Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Monoclonal Antibody Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Monoclonal Antibody Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Monoclonal Antibody Therapeutics Revenue Market Share by Application (2016-2021)
Table 29. Global Monoclonal Antibody Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Monoclonal Antibody Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Monoclonal Antibody Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Monoclonal Antibody Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Monoclonal Antibody Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Monoclonal Antibody Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Monoclonal Antibody Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Monoclonal Antibody Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Monoclonal Antibody Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Monoclonal Antibody Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Monoclonal Antibody Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Monoclonal Antibody Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Monoclonal Antibody Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Monoclonal Antibody Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Monoclonal Antibody Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Monoclonal Antibody Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Monoclonal Antibody Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Monoclonal Antibody Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Monoclonal Antibody Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Monoclonal Antibody Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Bayer Company Details
Table 62. Bayer Business Overview
Table 63. Bayer Monoclonal Antibody Therapeutics Product
Table 64. Bayer Revenue in Monoclonal Antibody Therapeutics Business (2016-2021) & (US$ Million)
Table 65. Bayer Recent Development
Table 66. F. Hoffmann-La Roche Company Details
Table 67. F. Hoffmann-La Roche Business Overview
Table 68. F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Product
Table 69. F. Hoffmann-La Roche Revenue in Monoclonal Antibody Therapeutics Business (2016-2021) & (US$ Million)
Table 70. F. Hoffmann-La Roche Recent Development
Table 71. Pfizer Company Details
Table 72. Pfizer Business Overview
Table 73. Pfizer Monoclonal Antibody Therapeutics Product
Table 74. Pfizer Revenue in Monoclonal Antibody Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Pfizer Recent Development
Table 76. Sanofi Company Details
Table 77. Sanofi Business Overview
Table 78. Sanofi Monoclonal Antibody Therapeutics Product
Table 79. Sanofi Revenue in Monoclonal Antibody Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Sanofi Recent Development
Table 81. GlaxoSmithKline Company Details
Table 82. GlaxoSmithKline Business Overview
Table 83. GlaxoSmithKline Monoclonal Antibody Therapeutics Product
Table 84. GlaxoSmithKline Revenue in Monoclonal Antibody Therapeutics Business (2016-2021) & (US$ Million)
Table 85. GlaxoSmithKline Recent Development
Table 86. Merck Company Details
Table 87. Merck Business Overview
Table 88. Merck Monoclonal Antibody Therapeutics Product
Table 89. Merck Revenue in Monoclonal Antibody Therapeutics Business (2016-2021) & (US$ Million)
Table 90. Merck Recent Development
Table 91. Novartis Company Details
Table 92. Novartis Business Overview
Table 93. Novartis Monoclonal Antibody Therapeutics Product
Table 94. Novartis Revenue in Monoclonal Antibody Therapeutics Business (2016-2021) & (US$ Million)
Table 95. Novartis Recent Development
Table 96. AbbVie Company Details
Table 97. AbbVie Business Overview
Table 98. AbbVie Revenue in Monoclonal Antibody Therapeutics Business (2016-2021) & (US$ Million)
Table 99. AbbVie Recent Development
Table 100. Amgen Company Details
Table 101. Amgen Business Overview
Table 102. Amgen Monoclonal Antibody Therapeutics Product
Table 103. Amgen Revenue in Monoclonal Antibody Therapeutics Business (2016-2021) & (US$ Million)
Table 104. Amgen Recent Development
Table 105. Johnson & Johnson Company Details
Table 106. Johnson & Johnson Business Overview
Table 107. Johnson & Johnson Monoclonal Antibody Therapeutics Product
Table 108. Johnson & Johnson Revenue in Monoclonal Antibody Therapeutics Business (2016-2021) & (US$ Million)
Table 109. Johnson & Johnson Recent Development
Table 110. Bristol-Myers Squibb Company Company Details
Table 111. Bristol-Myers Squibb Company Business Overview
Table 112. Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Product
Table 113. Bristol-Myers Squibb Company Revenue in Monoclonal Antibody Therapeutics Business (2016-2021) & (US$ Million)
Table 114. Bristol-Myers Squibb Company Recent Development
Table 115. Biogen Company Details
Table 116. Biogen Business Overview
Table 117. Biogen Monoclonal Antibody Therapeutics Product
Table 118. Biogen Revenue in Monoclonal Antibody Therapeutics Business (2016-2021) & (US$ Million)
Table 119. Biogen Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Monoclonal Antibody Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Humanized Antibody Features
Figure 3. Human Mouse Chimeric Antibody Features
Figure 4. Global Monoclonal Antibody Therapeutics Market Share by Application: 2020 VS 2027
Figure 5. Cancer Case Studies
Figure 6. Autoimmune Diseases Case Studies
Figure 7. Infection Case Studies
Figure 8. Hematological Diseases Case Studies
Figure 9. Ophthalmological Diseases Case Studies
Figure 10. Others Case Studies
Figure 11. Monoclonal Antibody Therapeutics Report Years Considered
Figure 12. Global Monoclonal Antibody Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Monoclonal Antibody Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Monoclonal Antibody Therapeutics Market Share by Regions: 2020 VS 2027
Figure 15. Global Monoclonal Antibody Therapeutics Market Share by Regions (2022-2027)
Figure 16. Global Monoclonal Antibody Therapeutics Market Share by Players in 2020
Figure 17. Global Top Monoclonal Antibody Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Antibody Therapeutics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Monoclonal Antibody Therapeutics Revenue in 2020
Figure 19. Global Monoclonal Antibody Therapeutics Revenue Market Share by Type (2016-2021)
Figure 20. Global Monoclonal Antibody Therapeutics Revenue Market Share by Type (2022-2027)
Figure 21. North America Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Monoclonal Antibody Therapeutics Market Share by Type (2016-2027)
Figure 23. North America Monoclonal Antibody Therapeutics Market Share by Application (2016-2027)
Figure 24. North America Monoclonal Antibody Therapeutics Market Share by Country (2016-2027)
Figure 25. United States Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Monoclonal Antibody Therapeutics Market Share by Type (2016-2027)
Figure 29. Europe Monoclonal Antibody Therapeutics Market Share by Application (2016-2027)
Figure 30. Europe Monoclonal Antibody Therapeutics Market Share by Country (2016-2027)
Figure 31. Germany Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Monoclonal Antibody Therapeutics Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Monoclonal Antibody Therapeutics Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Monoclonal Antibody Therapeutics Market Share by Region (2016-2027)
Figure 41. China Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Monoclonal Antibody Therapeutics Market Share by Type (2016-2027)
Figure 49. Latin America Monoclonal Antibody Therapeutics Market Share by Application (2016-2027)
Figure 50. Latin America Monoclonal Antibody Therapeutics Market Share by Country (2016-2027)
Figure 51. Mexico Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Monoclonal Antibody Therapeutics Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Monoclonal Antibody Therapeutics Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Monoclonal Antibody Therapeutics Market Share by Country (2016-2027)
Figure 57. Turkey Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Monoclonal Antibody Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Bayer Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2016-2021)
Figure 61. F. Hoffmann-La Roche Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2016-2021)
Figure 63. Sanofi Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2016-2021)
Figure 64. GlaxoSmithKline Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2016-2021)
Figure 65. Merck Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2016-2021)
Figure 66. Novartis Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2016-2021)
Figure 67. AbbVie Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2016-2021)
Figure 68. Amgen Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2016-2021)
Figure 69. Johnson & Johnson Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2016-2021)
Figure 70. Bristol-Myers Squibb Company Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2016-2021)
Figure 71. Biogen Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs